Seeking Alpha

Baxter International (BAX) initiates advanced clinical testing of its BAX 855 treatment for...

Baxter International (BAX) initiates advanced clinical testing of its BAX 855 treatment for hemophilia A. The firm says the phase I trial is the first step in assessing if the drug can be infused less frequently.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)